Published in Am J Respir Cell Mol Biol on November 01, 1997
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52
Physiology and pathophysiology of matrix metalloproteases. Amino Acids (2010) 1.83
POVME: an algorithm for measuring binding-pocket volumes. J Mol Graph Model (2010) 1.75
Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol (2008) 1.71
Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J (2004) 1.64
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.48
Mechanical stress is communicated between different cell types to elicit matrix remodeling. Proc Natl Acad Sci U S A (2001) 1.45
Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol (2002) 1.45
Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int (2010) 1.29
Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol (2014) 1.12
Airway remodelling in asthma: from benchside to clinical practice. Can Respir J (2010) 1.11
Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma. Thorax (2005) 1.10
The role of metalloelastase in immune complex-induced acute lung injury. Am J Pathol (2001) 1.06
A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice. J Immunol (2009) 1.04
PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res (2005) 1.04
Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax (1999) 1.02
Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation. Environ Health Perspect (2007) 0.98
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells. Thorax (2003) 0.97
Role of metalloelastase in a model of allergic lung responses induced by cockroach allergen. Am J Pathol (2004) 0.96
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors. J Mol Recognit (2010) 0.93
Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Br J Cancer (2003) 0.89
Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features. Clin Transl Allergy (2012) 0.87
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors. Chem Biol Drug Des (2011) 0.86
Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis. Respir Res (2011) 0.85
GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation. Proc Natl Acad Sci U S A (2016) 0.84
CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2. Int J Clin Exp Pathol (2015) 0.80
Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma. ISRN Allergy (2013) 0.79
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma. Arch Immunol Ther Exp (Warsz) (2015) 0.79
CTGF upregulation correlates with MMP-9 level in airway remodeling in a murine model of asthma. Arch Med Sci (2016) 0.77
The TNF Family Molecules LIGHT and Lymphotoxin αβ Induce a Distinct Steroid-Resistant Inflammatory Phenotype in Human Lung Epithelial Cells. J Immunol (2015) 0.77
Diospyros blancoi attenuates asthmatic effects in a mouse model of airway inflammation. Inflammation (2012) 0.77
Inhaled corticosteroids do not reduce initial high activity of matrix metalloproteinase (MMP)-9 in exhaled breath condensates of children with asthma exacerbation: a proof of concept study. Cent Eur J Immunol (2016) 0.75
Effect of tumor necrosis factor family member LIGHT (TNFSF14) on the activation of basophils and eosinophils interacting with bronchial epithelial cells. Mediators Inflamm (2014) 0.75
Decreased Homodimerization and Increased TIMP-1 Complexation of Uteroplacental and Uterine Arterial Matrix Metalloproteinase-9 during Hypertension-in-Pregnancy. Biochem Pharmacol (2017) 0.75
Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma. Inflammation (2016) 0.75
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
Resistance studies with daptomycin. Antimicrob Agents Chemother (2001) 3.63
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Quantitative analysis of high-resolution trypsin-giemsa bands on human prometaphase chromosomes. Hum Genet (1978) 3.13
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77
Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33
Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13
Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08
Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91
Sputum induction. Eur Respir J Suppl (2002) 1.88
Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82
Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J (2002) 1.79
Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76
Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy (2007) 1.75
Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75
Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax (2009) 1.74
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72
Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71
A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70
Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68
Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68
Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67
Chloroplast and nuclear gene sequences indicate late Pennsylvanian time for the last common ancestor of extant seed plants. Proc Natl Acad Sci U S A (1994) 1.66
Iatrogenic eosinophilic pleural effusion. Eur Respir Rev (2011) 1.63
Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy (2007) 1.63
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy (2004) 1.61
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy (2005) 1.59
Molecular evolution of angiosperm mitochondrial introns and exons. Proc Natl Acad Sci U S A (1997) 1.56
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
[Smoking habits, attitudes and knowledges of medical students of Medicine, Pharmacy and Odonto-Stomatology's Faculty of Dakar, Senegal]. Rev Mal Respir (2003) 1.54
Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy (2013) 1.54
Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med (1997) 1.54
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50
Update on severe asthma: what we know and what we need. Eur Respir Rev (2009) 1.50
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology (1986) 1.50
Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol (1991) 1.50
Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.50
Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr (1997) 1.49
Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ (2001) 1.48
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Epidemiology of cypress pollen allergy in Montpellier. J Investig Allergol Clin Immunol (2012) 1.45
Compliance in asthma. Respir Med (1999) 1.44
Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. J Rheumatol (1997) 1.43
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell (1983) 1.42
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy. J Allergy Clin Immunol (1980) 1.40
Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol (1993) 1.39
[Non-communicable chronic diseases, a global public health priority recognized by the United Nations]. Presse Med (2011) 1.39
[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal]. Rev Mal Respir (2004) 1.39
[Gastric site of epidermoid carcinoma]. Presse Med (1997) 1.39
[Analysis of induced sputum in the management of asthma: a valid technique, a service rendered by community pneumonologists]. Rev Mal Respir (2002) 1.38
Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol (2000) 1.38
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation]. Rev Mal Respir (2013) 1.38
Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem (1987) 1.36
Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy (2007) 1.35
Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35
The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33
Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res (1988) 1.30
Asthma: a disease remodeling the airways. Allergy (1992) 1.30
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30
Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy (2011) 1.29
IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol (1998) 1.28
GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy (2010) 1.28